Recoxitro 90 mg 30 tablets
Marcyrl Pharmaceutical Industries
Marcyrl Pharmaceutical Industries
The medication is based on etoricoxib and is used for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain syndromes. It has pronounced anti-inflammatory and analgesic effects.
Composition (per 1 tablet)
• Etoricoxib – 90 mg
Pharmacological properties
Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor, a key enzyme in the synthesis of prostaglandins that cause inflammation, pain, and swelling.
Due to its selective action on COX-2 (with minimal effect on COX-1), etoricoxib reduces pain and inflammation while lowering the risk of gastroduodenal complications common with traditional NSAIDs.
Indications for use
• Osteoarthritis
• Rheumatoid arthritis
• Ankylosing spondylitis
• Acute pain, including postoperative and dental pain
• Gouty arthritis (acute attack).
Dosage and administration
• Osteoarthritis: 60 mg once daily
• Rheumatoid arthritis, ankylosing spondylitis: 90 mg once daily
• Acute dental pain: up to 90 mg once daily, short-term use
• Acute gouty arthritis: 120 mg once daily, maximum 8 days.
The tablet should be taken regardless of meals. Taking it with food may delay the onset of action.